|
|
 | |  | | | ARNOLFO | 09:30 - 12:30
--CARDIOVASCULAR PATHOLOGY - SUDDEN CARDIAC DEATH WITH APPARENTLY NORMAL HEARTS |  | |  | | Thiene G.
Anomalies of the conduction system |
| |  | |  |
| | | | D'Amati G.
Ion channel diseases and molecular autopsy |
| | | | |
| | | | Fornes P.
The help of toxicology |
| | | | |
| | | | Basso C.
Fatty heart and sudden death |
| | | | |
| |
15:00 - 18:00
--CARDIOVASCULAR PATHOLOGY - CARDIOVASCULAR PATHOLOGY SHORT COURSE AND BUSINESS MEETING | | | | | Dalager S.
Clinicopathological case presentations |
| | | | |
| | | | Fedrigo M.
Clinical pathological case |
| | | | |
| | | | Dalager S.
Young man in van |
| | | | |
| |
18:00 - 19:30
--CARDIOVASCULAR PATHOLOGY - LESSON OF ANATOMY. HOW-TO STUDY HEARTS FROM SUDDEN CARDIAC DEATH | | | | | Thiene G.
Guidelines for autopsy investigation |
| | | | |
| | | | Basso C.
Video demostration |
| | | | |
| |
|
| |  | |  |
| | | | | BOTTICELLI | 09:30 - 12:30
--CYTOPATHOLOGY - GETTING CLOSER TO DEEP MASSES - ENDOSONOGRAPHY GUIDED FNA - JOINT SESSION BETWEEN ESP CYTOPATHOLOGY WG AND AMERICAN SOCIETY OF CYTOPATHOLOGY | | | | | Nayar R.
Endoscopic ultrasound: a clinical view point |
| | | | |
| | | | Svjatoha V.
EUS principles and technical issues - From a cytopathologist point of view |
| | | | |
| | | | Hoda R.
Pancreatic lesions ? Cytomorphologic challenges in solid and cystic lesions |
| | | | |
| | | | Zeppa P.
Impact of EUS / EBUS in mediastinal and lung lesions: advantages, limitations, pitfalls and on-site evaluation |
| | | | |
| | | | Schmitt F.
Ancillary studies in EUS FNA |
| | | | |
| | | | Nayar R.
Case Presentations |
| | | | |
| |
15:00 - 18:00
--CYTOPATHOLOGY - CYTOPATHOLOGY OF THE CERVIX - BASICS AND CHALLENGES | | | | | Bonito L. Di
Cervical squamous lesions |
| | | | |
| | | | Bergeron C.
Cervical glandular lesions |
| | | | |
| | | | Bergeron C.
Selection of challenging cases |
| | | | |
| | | | Bonito L. Di
Selection of challenging cases |
| | | | |
| |
18:00 - 19:30
--ORAL PRESENTATIONS - CYTOPATHOLOGY | | | | | Nicolaevich A. Filipovich
Activity criteria of demyelinizati on process |
| | | | |
| | | | Malapelle U.
KRAS mutation testing on matched cytological and histological specimens of metastatic colo-rectal cancer |
| | | | |
| | | | Pohar Marinsek Z.
Pitfalls in FNA of lipomatous tumours |
| | | | |
| | | | Fokter A. Repse
Review of negative or low grade smears in women with invasive cervical cancer in Slovenia |
| | | | |
| | | | Kornegoor R.
Thin layer cytology and immunocytochemistry in pleural fluids and ascites: quick and accurate |
| | | | |
| | | | Metze K.
Fractal characteristics of nuclear chromatin in routinely stained cytology are independent prognostic factors in patients with multiple myeloma |
| | | | |
| | | | Fokter A. Repse
Rapid pre-screening as a quality assurance measure in cervical cytology |
| | | | |
| | | | Sugrue C.
Performance appraisail for cytologists: an experience from the United States |
| | | | |
| | | | Panelos I.
Preliminary investigation of the clinical relevance of detecting circulating tumour cells by isolation by size of epithelial tumour cells (ISET) technique from cutaneous melanoma patients |
| | | | |
| |
|
| | | | |
| | | | | BRUNELLESCHI | 09:30 - 12:30
--PAEDIATRIC AND PERINATAL PATHOLOGY - PAEDIATRIC TUMOUR PATHOLOGY | | | | | Frank S.
Pediatric brain tumours (for adults only) |
| | | | |
| | | | Leuschner I.
Rhabdomyosarcomas |
| | | | |
| | | | de Krijger R.
Essentials on endocrine tumours in children: morphologic and molecular aspects of diagnosis and impact on patient management |
| | | | |
| | | | Kelsey A.
The incidence of soft tissue sarcomas in adolescents and young adults. A review of current knowledge |
| | | | |
| | | | Bruder E.
Bone tumour biopsies in children |
| | | | |
| | | | Luthert P.
Update on ocular and orbital tumours of childhood and adolescence |
| | | | |
| | | | Ernestus K.
Neuroblastic tumours in childhood: sample handling and networking for rare tumours |
| | | | |
| |
15:00 - 18:00
--PAEDIATRIC AND PERINATAL PATOLOGY - PERINATAL PATHOLOGY: SIGNIFICANT PLACENTAR LESIONS | | | | | Dahlstrom J.
Chronic villitis and intervillositis, an update |
| | | | |
| | | | Cox P.
Placental pathology of twin-twin transfusion syndrome |
| | | | |
| | | | Rougemont A.L.
Vascular lesions of the placenta |
| | | | |
| | | | Gillan J.
How the autopsy can explain over 90% of perinatal deaths |
| | | | |
| | | | Rizzo G.
Ultrasonographic assessment of placental volume and 3D vascularisation in first trimester normal and abnormal pregnancies |
| | | | |
| |
18:00 - 19:30
--PAEDIATRIC AND PERINATAL PATHOLOGY - PAEDIATRIC AND PERINATAL PATHOLOGY BUSINESS MEETING | | | | | Oligny L.
Molecular diagnostic techniques - An overview |
| | | | |
| | | | Reyes-Múgica M.
Cancer predisposition syndromes in children: lesions seemingly trivial with potential significance |
| | | | |
| |
|
| | | | |
| | | | | CIMABUE | 09:30 - 12:30
--HAEMATOPATHOLOGY - WHO CLASSIFICATION | | | | | Campo E.
Small B-cell lymphomas |
| | | | |
| | | | Kluin P.M.
Diffuse large B-cell lymphoma, NOS and variants |
| | | | |
| | | | Leoncini L.
Role of EBV in microRNA dysregulati on in Burkitt lymphoma |
| | | | |
| | | | Piris M.A.
T-cell lymphomas in the WHO classification |
| | | | |
| | | | Kreipe H.
Myeloid neoplasms |
| | | | |
| |
15:00 - 18:00
--HAEMATOPATHOLOGY - MICROENVIRONMENT AND LYMPHOMAGENESIS | | | | | de Jong D.
Microenvironment in follicular lymphoma |
| | | | |
| | | | Ghia P.
T cells and the microenvironment in B-CLL |
| | | | |
| | | | Poppema S.
The paradigm of the microenvironment in Hodgkin lymphoma |
| | | | |
| | | | Gaulard P.
T cell lymphomas and their microenvironment |
| | | | |
| |
18:00 - 18:30
--GUEST LECTURE | | | | | Weisenburger D.D.
Update on mantle cell lymphoma |
| | | | |
| |
18:30 - 19:30
--ORAL PRESENTATIONS - HAEMATOPATHOLOGY | | | | | Manxhuka-Kerliu S.
Diffuse large B-cell lymphoma-clear cell variant. Case report |
| | | | |
| | | | Kurrer M.
Intact B cell follicles identify mixed cellularity (MC) Hodgkin lymphomas (HL) with clinical and prognostic features of lymphocyte rich classical HL (CHL) |
| | | | |
| | | | Hamed H. Ibrahim Ahmed
Aberrant hypermethylation of DAP-kinase CPG island in immune suppression associated B-cell lymphoproliferative disorders/ lymphomas and immune competent diffuse large B-cell lymphoma. Correlation with EBV-association |
| | | | |
| | | | Martinez D.
Accelerated CLL is a morphological variant involving lymphoid tissues with high proliferation and prognostic implications |
| | | | |
| | | | Hamed H. Ibrahim Ahmed
Epstein Barr virus genotypes in immunodeficiency lymphoproliferative disorders/lymphomas |
| | | | |
| | | | Mezei T.
Prognostic markers and angiogenesis in diffuse large B-cell lymphoma and follicular lymphoma |
| | | | |
| |
|
| | | | |
| | | | | DELLA-ROBBIA | 09:30 - 12:30
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: GYNAECOLOGICAL PATHOLOGY | | |
15:00 - 18:00
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: DERMATOPATHOLOGY THE APPROACH TO AMBIGUOUS CUTANEOUS MELANOCYTIC LESIONS | | |
18:00 - 19:30
--ORAL PRESENTATIONS - DERMATOPATHOLOGY | | | | | Stoemmer Erasmus P.
Cell adhesion molecules cadherins E, N, P and catenins in nevi and melanomas |
| | | | |
| | | | Schmidt A.
Patterns of MCV in Merkel cell carcinoma (MCC) analyzed by fluorescence in situ hybridization (FISH) |
| | | | |
| | | | Santi R.
Analysis of tumour suppressor gene TP53 mutations in atypical vascular lesions of the breast skin following radiotherapy |
| | | | |
| | | | Stoemmer Erasmus P.
Cell cycle regulator p16INK4a in cutaneous cylindromas and spiradenomas and its role as a morphogenetic factor |
| | | | |
| | | | Massi D.
Expression of neural crest stem cells markers in cutaneous amelanotic melanomas |
| | | | |
| | | | Jozsef T.
Gene signature of the metastatic potential of cutaneous melanoma: a meta-analysis |
| | | | |
| | | | Fondi C.
Histopathology of cutaneous GvHD in the era of reduced-intensity conditioning |
| | | | |
| | | | Krenacst T.
Malignant melanomas can be differentiated from atypical nevi by collagen XVII expression, which can be a target of immunotherapy |
| | | | |
| | | | Luzar B.
Morphological and immunohistochemical features of atypical fibroxanthoma. Potential diagnostic pitfalls |
| | | | |
| |
|
| | | | |
| | | | | GIOTTO | 09:30 - 12:30
--HEAD AND NECK PATHOLOGY - CURRENT TOPICS IN HEAD AND NECK PATHOLOGY - IN MEMORY OF MARIO A. LUNA | | | | | Leivo I.
In Memoriam Mario Luna |
| | | | |
| | | | Ellis G.
AFIP series 4 atlas. Tumours of the salivary glands. What's new? |
| | | | |
| | | | Fonseca I.
Molecular pathology of mucoepidermoid carcinoma |
| | | | |
| | | | Reis-Filho J.S.
Molecular approach to adenoid cystic carcinoma of salivary glands and breast |
| | | | |
| | | | Slootweg P.
Fibrous and myxoid lesions of the maxillofacial bones |
| | | | |
| | | | Ordi J.
Human papillomavirus in head and neck cancer |
| | | | |
| |
15:00 - 18:00
--HEAD AND NECK PATHOLOGY - CONTROVERSIES IN HEAD AND NECK PATHOLOGY - IN MEMORY OF MARIO A. LUNA | | | | | Gale N.
Dilemmas of laryngeal squamous intraepithelial lesions |
| | | | |
| | | | Hamilton Therkildsen M.
The value of sentinel lymph node in H&N malignancy |
| | | | |
| | | | Cardesa A.
Verrucous carcinoma of the head and neck: a tumour with a long and controversial history |
| | | | |
| | | | Foschini M.P.
How do we report head and neck cancers? Results of a EU questionnaire |
| | | | |
| |
18:00 - 19:30
--HEAD AND NECK PATHOLOGY- HEAD AND NECK BUSINESS MEETING - IN MEMORY OF MARIO A. LUNA | | | | | Di Palma S.
What have we learned from an 18 year old working group? |
| | | | |
| | | | Hamilton Therkildsen M.
Head and neck working group: how to become a new member? |
| | | | |
| | | | Di Palma S., El Mofty S.
Planning for new avenues |
| | | | |
| |
|
| | | | |
| | | | | LEONARDO | 09:30 - 12:30
--BREAST PATHOLOGY - UPDATE IN BREAST PATHOLOGY | | | | | Brogi E.
What are the implications of intratumoural heterogeneity |
| | | | |
| | | | Ellis I.O.
The low nuclear grade breast neoplasia family: concepts and evidence |
| | | | |
| | | | Tot T.
Molecular clock, sick lobe and diagnostic routine |
| | | | |
| | | | Reis-Filho J.S.
Will expression profiling finally replace histopathology? |
| | | | |
| | | | Eusebi V.
Benign and malignant spindle cell tumours of the breast |
| | | | |
| |
15:00 - 18:00
--BREAST PATHOLOGY - INTRAEPITHELIAL LESIONS AND OTHER NOVELTIES IN BREAST PATHOLOGY | | | | | Tavassoli F.A.
Novel variants of lobular intraepithelial neoplasia: morphologic and molecular features |
| | | | |
| | | | Penault-Llorca F.
Gene expression profile based predictive assays: oncotype DX and mammaprint |
| | | | |
| | | | Dahlstrom J.
Multifocal and multi centric breast cancer: a reappraisal |
| | | | |
| | | | Moinfar F.
Role of microenvironment in breast cancer |
| | | | |
| | | | Viale G.
Personalized treatment in breast cancer |
| | | | |
| |
18:00 - 19:30
--BREAST PATHOLOGY - ESP BREAST PATHOLOGY WG & ISBP & EWGBSP JOINT MEETING | | | | | Bussolati G.
Shape of nuclei in breast cancer: towards a more objective evaluation |
| | | | |
| | | | Tallini G.
Oncocytic tumours of the breast |
| | | | |
| | | | Wells C.
Apocrine cells and breast lesions, a sign of benignity? |
| | | | |
| | | | Bianchi S.
Microinvasive carcinoma of the breast: what is it, how can it be diagnosed reliably and is it clinically significant? |
| | | | |
| |
|
| | | | |
| | | | | MASACCIO | 09:30 - 12:30
--LIVER PATHOLOGY - MIMICS IN LIVER PATHOLOGY | | | | | Van Eyken P.
Viral hepatitis versus primary biliary cirrhosis |
| | | | |
| | | | Terlizzo M.
Drug reaction versus primary biliary cirrhosis |
| | | | |
| | | | Guido M.
Autoimmune hepatitis versus viral hepatitis |
| | | | |
| | | | Hytiroglou P.
Hepatocellular adenoma versus hepatocellular carcinoma |
| | | | |
| | | | Faa G.
Hemochromatosis versus Wilson disease |
| | | | |
| |
15:00 - 18:00
--NEUROPATHOLOGY - UPDATE IN NEURO-ONCOLOGY | | | | | Buccoliero A.M.
Pediatric neuro-oncologgy: the Florentine experience |
| | | | |
| | | | Giangaspero F.
Glio-neuronal tumours and glial tumours with neuronal differentiation: a need of clarity |
| | | | |
| | | | Giannini C.
Malignant lymphoma of the central nervous system |
| | | | |
| | | | Roncaroli F.
The pathology of the sella: new entities and revised concepts |
| | | | |
| | | | Daumas-Duport C.
Common forms of gliomas: Sainte-Anne classification and diagnostic approach |
| | | | |
| |
18:00 - 19:30
--NEUROPATHOLOGY - MENINGEAL TUMOURS | | |
|
| | | | |
| | | | | MICHELANGELO | 08:30 - 09:30
--OPENING CEREMONY | | |
09:30 - 12:30
--UROLOGICAL PATHOLOGY - KIDNEY CANCER: THE IMPACT OF DIFFERENT HISTOLOGICAL SUBTYPES ON THE THERAPY | | | | | Grignon D.
Morphological subtyping of renal cell carcinoma |  |
| | | | |
| | | | Delahunt B.
Grading and staging of renal cell carcinoma. Advances and controversies | |
| | | | |
| | | | Moch H.
Molecular basis of renal cancer treatment | |
| | | | |
| | | | Martignoni G.
Usual and carcinoma-like epithelioid angiomyolipomas: morpho-molecular phenotype, mTOR pathways and therapy | |
| | | | |
| | | | Renner C.
Studies of CA-IX for imaging and therapy in renal cancer | |
| | | | |
| |
12:30 - 13:30
--KEYNOTE LECTURE - SYMEONIDIS LECTURE | | |
15:00 - 19:30
--UROLOGICAL PATHOLOGY - PROSTATE CANCER.[...] | | | | | Berney D.
The natural history of prostate cancer | |
| | | | |
| | | | Mikuz G.
Molecular cytogenetic of prostate cancer, precursor lesions and malignancy associated changes | |
| | | | |
| | | | Billis A.
Mimics of adenocarcinoma on needle prostatic biopsy | |
| | | | |
| | | | Srigley J.
High grade prostatic intraepithelial neoplasia and glandular atypia (ASAP): risk factors for adenocarcinoma | |
| | | | |
| | | | Grignon D.
Histological variations and variants of prostatic adenocarcinoma | |
| | | | |
| | | | Humphrey P.
Update on pathological staging of prostate cancer: results of the 2009 International Society of Urological Consensus Meeting | |
| | | | |
| |
|
| | | | |
| | | | | RAFFAELLO | 09:30 - 12:30
--DIGESTIVE DISEASES PATHOLOGY- ROLE OF PATHOLOGIST IN TARGETED THERAPY OF GI TUMOURS | | | | | Nagtegaal I.
Assessment of preoperative therapy effect in colorectal cancer |
| | | | |
| | | | van Krieken J.H.J.M.
Predicting response of EGFr-blocking |
| | | | |
| | | | Kirchner T.
Mismatch repair deficiency and therapy effect |
| | | | |
| | | | Röcken C.
Predictive factors in colorectal cancer |
| | | | |
| |
13:30 - 15:00
--SATELLITE SYMPOSIUM NOVARTIS - GIST AND NET: TARGETED THERAPIES AND NOVEL TREATMENT STRATEGIES | | | | | Dei Tos A.P.
Welcome and introduction: the crucial role of the pathologist in optimizing tumour control |
| | | | |
| | | | Dei Tos A.P.
From molecular biology to therapy: imatinib - a success story in GIST |
| | | | |
| | | | Papotti M.
Improving diagnosis in NET and anatomopathological considerations |
| | | | |
| | | | Salazar R.
Current and future directions in NET treatment |
| | | | |
| | | | Dei Tos A.P.
Closing remarks |
| | | | |
| |
15:00 - 18:00
--DIGESTIVE DISEASES PATHOLOGY - GASTROINTESTINAL BIOPSY REPORTING: WHAT DO CLINICIANS WANT? | | | | | Doganavsargil B.
Esophagitis-what do clinicians want? |
| | | | |
| | | | Ristimäki A.
Gastric Polyps |
| | | | |
| | | | Rindi G.
Endocrine tumours |
| | | | |
| | | | Offerhaus J.
The gastroenterostoma after billroth antrectomy as a premalignant condition |
| | | | |
| |
18:00 - 19:30
--DIGESTIVE DISEASES PATHOLOGY - DIAGNOSTIC CHALLENGES IN GI PATHOLOGY | | |
|
| | | | |
| | | | | VASARI | 09:30 - 10:00
--GUEST LECTURE | | | | | Franco V.
Pathology in figurative arts: deeds and misdeeds |
| | | | |
| |
10:00 - 12:30
--ORAL PRESENTATIONS : ELECTRON MICROSCOPY - NEUROPATHOLOGY - MISCELLANEOUS | | | | | Wozniak A.
Immunohistochemical and electron-microscopic study in Henoch-Schoenlein nephritis |
| | | | |
| | | | Cervera P.
Remodeling of adipose ti ssue from lipodystrophic patients with LMNA mutations |
| | | | |
| | | | Mandache E.
Ultrastructural remodeling of cardiomyocytes during isolated atrial amyloidosis |
| | | | |
| | | | Stenram U.
A new variant of oralfacialdigital syndrome |
| | | | |
| | | | Bély M.
Ultrastructural characteristics of systemic and localized AL-lambda amyloid deposits |
| | | | |
| | | | Levidou G.
P53 as a prognosti c marker for astrocytic gliomas: a meta-analysis and review |
| | | | |
| | | | Sanz J.
Chromosome 1P36 loss and Cox-2 overexpression are independent predictors of recurrence in completely removed meningiomas Grade I and II. Analysis of their associati on with clinicopathological and immunohistochemical variables |
| | | | |
| | | | Pizem J.
Mitotic count and brain invasion are independent predictors of recurrence free survival in primary atypical and malignant meningiomas. A study of 86 patients |
| | | | |
| | | | Poliani L.P.
Dendritic cells from human peripheral lymphoid tissues express AiRe (autoimmune regulator) |
| | | | |
| | | | Stoica G.
Isolation of cancer stem cells from dog glioblastoma multiforme |
| | | | |
| | | | Fritzsche R.F.
Silver enhanced in situ hybridisati on detects of BK virus DNA in renal biopsies from renal transplant patients |
| | | | |
| | | | Schmauz R.
Malaria and malignant non-Burkitt -lymphomas. A review of studies from Uganda |
| | | | |
| |
15:00 - 18:00
--ESP / IAP JOINT SYMPOSIUM - GRAY ZONES IN ENDOCRINE PATHOLOGY AND PREDICTIVE MARKERS | | | | | McNicol A.M.
Diagnostic dilemmas in adrenal hyperplasia/adenoma/carcinoma |
| | | | |
| | | | Asa S.L.
Morphologic and molecular gray zones in thyroid proliferative disorders |
| | | | |
| | | | Osamura R.Y.
Part 1: Interphase of parathyroid hyperplasia/adenoma Part 2: Overlapping of neuroendocrine hyperplasia/tumour/ carcinoma and prognostic factors |
| | | | |
| | | | Scheithauer B.
Pituitary hyperplasia/adenoma/carcinoma sequence I |
| | | | |
| | | | Scheithauer B.
Pituitary hyperplasia/adenoma/carcinoma sequence II |
| | | | |
| | | | Kontogeorgos G.
Predictive markers of pituitary adenomas |
| | | | |
| |
18:00 - 19:30
--ORAL PRESENTATIONS - GYNAECOLOGICAL PATHOLOGY | | | | | Tong G.
Diagnostic and histogenetic significance of PAX8 expression in papillary serous carcinoma of the peritoneum |
| | | | |
| | | | Chun Y.
A multiinstitutional consensus study on the pathologic diagnosis of ovarian mucinous borderline tumours and adenocarcinomas |
| | | | |
| | | | Sarancone S.
Her-2 and ovarian cancer |
| | | | |
| | | | Iljazovic E.
The prevalence of mix HRHPV infection among women of reproductive age in Tuzla Canton, Bosnia and Herzegovina |
| | | | |
| | | | Castillo P.
Value of p16INK4a as a marker of progression/regression in cervical intraepithelial neoplasia grade 1 |
| | | | |
| | | | Fulciniti F.
Adhesion molecules and P16 expression in endocervical adenocarcinoma |
| | | | |
| | | | Cigdem B. Ege
Investigation of GLUT-1 and galectin-3 in endometrioid and serous carcinomas of the endometrium |
| | | | |
| | | | Kogan E.
Molecular basis of stromal-parenchymal interactions in foci of active and non-active adenomyosis |
| | | | |
| | | | Grechukhina O.
Morphogenetic relationships between foci of adenomyosis and basalis of eutopic endometrium |
| | | | |
| |
|
| | | | |
| | | | | ARNOLFO | 08:30 - 12:00
--STEM CELLS - CAN PATHOLOGIST CONTRIBUTE TO STEM CELL MEDICINE ADVANCE? | | | | | Guidi C.
Cell factory: scientific aims and management |
| | | | |
| | | | Pasquinelli G.
Stem cell engineered scaffolds: role of histopathological and ultrastructural investigations |
| | | | |
| | | | Cenacchi G.
Tissue specific adult stem cell: the satellite cell of skeletal muscle |
| | | | |
| | | | Calzà L.
Neural stem cells in pathological brains: insights for both stem cell biology and regenerative medicine |
| | | | |
| | | | Beltrami A.P.
Myocardial repair and heart adult stem cells |
| | | | |
| | | | Osamura R.Y.
Pathologic detection of stem cell markers in breast cancers and pituitary adenomas: its impact on the tumour pathobiology and therapy |
| | | | |
| |
14:30 - 17:00
--CARDIOVASCULAR PATHOLOGY - SURGICAL PATHOLOGY SLIDE SEMINAR | | |
17:30 - 19:00
--ORAL PRESENTATIONS - BREAST PATHOLOGY | | | | | Marchiò C.
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridisation and microarray-based CGH analysis |
| | | | |
| | | | Haxhiymeri O.
Effects of mammographic screening in Trieste (Italy) at the end of first round |
| | | | |
| | | | Makretsov N.
Evaluation of chromatin modifying enzymes and modified histones in breast cancer |
| | | | |
| | | | Simonetti S.
Expression pattern of CD24 and CD44 isoforms in micropapillary carcinoma of the breast |
| | | | |
| | | | Molinaro L.
Gene expression profiling in under-vacuum stored breast carcinomas: a pilot study |
| | | | |
| | | | Brunelli M.
Genotypic intratumoural heterogeneity in breast carcinoma with HER-2/NEU amplification: evaluation according to ASCO/CAP criteria |
| | | | |
| | | | Cannizzaro C.
Lower incidence of triple negative breast cancers within a screening program |
| | | | |
| | | | Decker T.
Margin width and size as predictors of residual tumour in breast conserving therapy of ductal carcinoma in situ |
| | | | |
| | | | Marchiò C.
Mixed micropapillary-ductal carcinomas of the breast: a genomic and immunohistochemical analysis of morphologically distinct components |
| | | | |
| |
|
| | | | |
| | | | | BOTTICELLI | 08:30 - 12:00
--PATHOLOGY HISTORY - WHAT EVERY PATHOLOGIST SHOULD KNOW ABOUT THE HISTORY OF PATHOLOGY | | | | | Amr S.S.
The contributions of Arab and Muslim civilization to medicine |
| | | | |
| | | | Scarani P.
he men who influenced Morgagni as anatomist |
| | | | |
| | | | van den Tweel J.G.
The men who influenced Morgagni as a pathologist |
| | | | |
| | | | Nesi G.
Wax models as teaching tools in anatomy and pathology |
| | | | |
| | | | Müller-Hermelink H.K.
Rudolf Virchow and the history of German pathology in the 19th century |
| | | | |
| |
13:00 - 14:30
--SATELLITE SYMPOSIUM DAKO - PROCESS IMPROVEMENTS IN PATHOLOGY FOR PATIENT SAFETY AND DIAGNOSTIC ACCURACY | | | | | Norring Hjort K.
Introduction |
| | | | |
| | | | Dei Tos A.P.
Welcome by Moderator |
| | | | |
| | | | Michel R.L.
Workflow improvement. The transformation of pathology: trends and changes |
| | | | |
| | | | Ejlertsen B.
Prediction of responsiveness to adjuvant anthracyclines in high risk breast cancer patients |
| | | | |
| | | | Viale G.
Recent efforts to standardize ER and PgR assays in breast cancer: the ASCO/CAP recommendations and the FDA approval of immunohistochemical markers |
| | | | |
| |
14:30 - 17:00
--CYTOPHATOLOGY - CYTOPATHOLOGY SLIDE SEMINAR: IS IT CANCER? PITFALLS ON FNA | | |
17:30 - 19:00
--CYTOPHATOLOGY - HOW I REPORT FNA | | | | | Firat P.
Administrative Affairs |
| | | | |
| |
|
| | | | |
| | | | | BRUNELLESCHI | 08:30 - 12:00
--PANCREAS PATHOLOGY - PANCREAS PATHOLOGY SYMPOSIUM | | | | | Klimstra D.S.
Analgorytmic approach to diagnosis |
| | | | |
| | | | Manfrin E.
Integrated radiologic and cytologic diagnostic approach |
| | | | |
| | | | Klöppel G.
Pancreatic intraductal papillary-mucinous neoplasms of gastric type and pancreatic intraepithelial neoplasia disease |
| | | | |
| | | | Terris B.
Comparison of pancreatic IPMN with biliary IPMN |
| | | | |
| | | | Adsay V.
Intraductal tubular carcinomas of the pancreas |
| | | | |
| | | | Zamboni G.
Non-neoplastic mimickers of pancreatic neoplasms |
| | | | |
| | | | Campbell F.
Hereditary pancreatitis and the risk of pancreatic ductal adenocarcnoma |
| | | | |
| | | | Bonetti F.
Closing remarks |
| | | | |
| |
13:00 - 14:30
--SATELLITE SYMPOSIUM ABBOTT MOLECULAR - MEANINGFUL DIAGNOSTICS IN WOMEN'S HEALTH | | | | | Poljak M.
The European Abbott RealTime High Risk HPV assay experience: results |
| | | | |
| | | | Depuydt C.
Molecular cytology with FISH as the perfect complement to HPV DNA testing |
| | | | |
| | | | Simon R.
Evidence for a new role of FISH in HER-2 testing |
| | | | |
| |
14:30 - 17:00
--PAEDIATRIC AND PERINATAL PATHOLOGY - PAEDIATRIC PATHOLOGY SLIDE SEMINAR | | |
17:30 - 19:00
--MOLECULAR PATHOLOGY - MOLECULAR PATHOLOGY ON PARAFFIN TISSUE | | | | | Bussolati G.
Pre-analytical treatment of tissues: the possibility of standardization |
| | | | |
| | | | Dietel M.
Expression profiling of archived tissue - New horizons in translational research |
| | | | |
| | | | Kirchner T.
KRAS mutation status as predictive tumour marker - The importance of quality assurance |
| | | | |
| | | | Becker K.F.
Proteomics of archived tissue - Recent progress |
| | | | |
| | | | Hoefler H.
Maldi-imaging of archived tissues - New opportunities |
| | | | |
| |
|
| | | | |
| | | | | CIMABUE | 08:30 - 12:00
--GYNAECOLOGICAL PATHOLOGY - UPDATES [...] | | | | | Carcangiu M.L.
The fallopian tube as primary source of serous adnexal and pelvic malignancies |
| | | | |
| | | | van Diest P.J.
Genetic background of fallopian tube malignancies and peritoneal lesions |
| | | | |
| | | | Gillespie A.M.
The role of prophylactic surgery in the gynaecological management of BRCA mutation carriers |
| | | | |
| | | | Hollema H.
Pathological findings in prophylactically removed adnexa in BRCA1/2 carriers |
| | | | |
| |
14:30 - 17:00
--GYNAECOLOGICAL PATHOLOGY - DIFFICULT CASES IN GYNECOPATHOLOGY | | | | | Giatromanolaki A.
DIFFICULT/INTERESTING CASES IN GYNECOPATHOLOGY-ECP 2009 |
| | | | |
| |
17:30 - 19:00
--GYNAECOLOGICAL PATHOLOGY - CONSULTANT EXPERIENCE OF 25 YEARS: "THE MISTAKE(S) WE MADE" | | |
|
| | | | |
| | | | | DELLA-ROBBIA | 08:30 - 12:00
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: DIGESTIVE DISEASES | | |
14:30 - 17:00
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: BREAST PATHOLOGY | | |
17:30 - 19:00
--ORAL PRESENTATIONS - BREAST PATHOLOGY | | | | | Martin V.
Analysis of molecular markers in basal-like breast cancers predict poor response to anti-EGFR targeted therapies |
| | | | |
| | | | Ellis I. O.
Columnar cell lesions are the early precursors of some forms of invasive breast carcinoma: a new genetic map for the evolutionary pathway of low nuclear grade breast neoplasia (LNGBN) family |
| | | | |
| | | | Flamminio F.
Genetic similarities and differences in duct carcinoma in situ of the breast |
| | | | |
| | | | Ellis I. O.
High resolution array comparative genomic hybridization (ACGH) identifies mouse double minutes 4 (MDM4) as one of the early genetic changes in breast cancer development: MDM4 is a new independent prognostic and predictive marker |
| | | | |
| | | | Shousha S.
A curious association between breast lobular neoplasia and proliferation of myoepithelial/basal cells |
| | | | |
| | | | Ichihara S.
A new method of complete shaved margin assessment to identify a subgroup of breast cancer patients who might not require radiation therapy, a cohort study in Japan |
| | | | |
| | | | Garcia Pravia C.
Anti COL11, a new marker of infiltrating breast cancer |
| | | | |
| | | | Elsberger B.
Are Src kinase family members (SKFMS) expressed in human breast cancer? |
| | | | |
| | | | Ragazzi M.
Characterization of oncocytic breast carcinoma |
| | | | |
| |
|
| | | | |
| | | | | GIOTTO | 08:30 - 12:00
--PULMONARY PATHOLOGY - PROBLEMATIC ISSUES IN PULMONARY PATHOLOGY | | | | | Popper H.
Granulomatous diseases |
| | | | |
| | | | Attanoos R.
Lymphoproliferative disorders |
| | | | |
| | | | Martignoni G.
Lymphangioleiomyomatosis and related lesions |
| | | | |
| | | | Chilosi M.
Histiocytic lesions |
| | | | |
| | | | Koss M.N.
Inflammatory pseudotumour (IPT) of the lung: a lesion of histological and etiological diversity |
| | | | |
| | | | Kerr K.M.
Pulmonary adenocarcinogenesis: concepts, classification and concerns |
| | | | |
| |
14:30 - 17:00
--PULMONARY PATHOLOGY - OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES | | |
17:30 - 19:00
--PULMONARY PATHOLOGY - PLEURAL DISEASES | | | | | Gibbs A.
New international guidelines: international WG pleural diseases |
| | | | |
| | | | Zeren E.H.
Pleura in occupational and environmental lung diseases |
| | | | |
| | | | Calabrese F.
Non-neoplastic pleural disease including collagen vascular and drug induced disorders |
| | | | |
| | | | Galateau-Salle F.
What's new in malignant mesothelioma? |
| | | | |
| |
|
| | | | |
| | | | | LEONARDO | 08:30 - 12:00
--BREAST PATHOLOGY - BREAST PATHOLOGY SLIDE SEMINAR | | | | | Foschini M.P.
Breast sarcoid |
| | | | |
| |
14:30 - 17:00
--DIGESTIVE DISEASES PATHOLOGY - BIOPSY DIAGNOSIS OF DIFFERENT FORMS OF COLITIS | | |
17:30 - 18:30
--DIGESTIVE DISEASES PATHOLOGY - MICROSCOPIC ESOPHAGITIS | | | | | Riddell R.H.
The role of esophageal histology in gastroesophageal reflux disease |
| | | | |
| | | | Vieth M.
Interobserver agreement in reporting microscopic esophagitis (the Esohisto project) |
| | | | |
| | | | Fiocca R.
Definition of lesions and assessment criteria (including a short digital slide seminar) |
| | | | |
| |
18:30 - 19:00
--ORAL PRESENTATIONS - DIGESTIVE DISEASES PATHOLOGY | | | | | Ferrer-Roca O.
Optical biopsy with confocal endoscopy diagnosed by pathologist |
| | | | |
| | | | Cataldo I.
Granular cell tumour of pancreas: a rare entity with a misleading presentation |
| | | | |
| | | | Detlefsen S.
Granular complement C3 positive immune complexes are overexpressed in autoimmune pancreatitis and located at the pancreatic ductal epithelium |
| | | | |
| |
|
| | | | |
| | | | | MASACCIO | 08:30 - 12:00
--HEAD AND NECK PATHOLOGY - HEAD AND NECK SLIDE SEMINAR - IN MEMORY OF MARIO A. LUNA | | | | | Guillou L.
Head and Neck Pathology Slide Seminar Case 4 |
| | | | |
| |
14:30 - 17:00
--HAEMATOPATHOLOGY - HAEMATOPATHOLOGY IN 2009: ROUTINE OR CHALLENGE? | | |
17:30 - 19:00
--ORAL PRESENTATIONS - ENDOCRINE PATHOLOGY | | | | | Serra S.
An FGFR4 polymorphism is implicated in the progression of neuroendocrine tumours |
| | | | |
| | | | Malinowska M.
Endocrine tumours of appendix. Presentation of 8 cases |
| | | | |
| | | | Bauersfeld J.
Genomic identification of biomarkers of behavior of pancreatic endocrine tumours |
| | | | |
| | | | La Rosa S.
Serotonin-producing pancreatic endocrine tumours (5HT-PETS): appropriate nomenclature and different biopathology with intestinal EC-cell tumours |
| | | | |
| | | | Schmitt M.A.
VHL and hypoxia signalling in sporadic pancreatic endocrine tumours |
| | | | |
| | | | Renaud F.
Analysis of thyroid tumours by a microscopic score combined with immunohistochemistry on tissue microarray (CK19, HBME1, galectin 3 and TPO) |
| | | | |
| | | | Michailidi C.
Evaluation of DNA repair related molecules expression in human benign and malignant thyroid lesions |
| | | | |
| | | | Volante M.
Increased FOXP3 positive lymphocytic infiltrates are associated to aggressive behaviour in papillary thyroid carcinoma |
| | | | |
| | | | Tsybrovskyy O.
Oncocytic and mitochondrion-rich follicular thyroid tumours: one spectrum of lesions or different pathways? |
| | | | |
| |
|
| | | | |
| | | | | MICHELANGELO | 08:30 - 12:00
--UROLOGICAL PATHOLOGY - BLADDER CANCER: FROM AETIOLOGY TO PREVENTION - CO-ORGANIZED WITH THE WORLD HEALTH ORGANIZATION COLLABORATING CENTRE FOR UROLOGIC TUMOURS, SWEDEN | | | | | Hartmann A.
Tissue microarray studies in bladder cancer | |
| | | | |
| | | | van der Kwast T.
How to combine the molecular profile with the clinical and pathological profile | |
| | | | |
| |
12:00 - 13:00
--KEYNOTE LECTURE | | | | | Thiene G.
Cardiovascular pathology: from the anatomical theatre to the double helix | |
| | | | |
| |
14:30 - 17:00
--UROLOGICAL PATHOLOGY - DIFFICULT CASES IN UROPATHOLOGY | | |
17:30 - 19:00
--UROLOGICAL PATHOLOGY - WHAT IS NEW AND IMPORTANT IN THE PATHOLOGY OF TESTICULAR TUMOURS | | |
|
| | | | |
| | | | | RAFFAELLO | 08:30 - 12:00
--DERMATOPATHOLOGY - NEW INSIGHT IN THE DIAGNOSIS AND BIOLOGY OF CUTANEOUS MELANOCYTIC LESIONS - IN MEMORY OF A. BERNARD ACKERMAN | | | | | Cerroni L.
Spitz nevi: change of perspective |
| | | | |
| | | | Busam K.J.
The role of sentinel lymph node biopsy for patients with diagnostically ambiguous Spitzoid melanocytic tumours |
| | | | |
| | | | Boit P. Le
Medical-legal issues in reporting cutaneous melanocytic lesions |
| | | | |
| | | | van den Oord J.J.
Gene expression profiling and melanoma progression: identification of prognostic genes, novel TSGs and miRNAs |
| | | | |
| | | | Maio M.
Epigenetic alterations in cutaneous melanoma |
| | | | |
| |
13:00 - 14:30
--SATELLITE SYMPOSIUM 3D HISTECH - DIGITAL HISTOLOGY | | | | | Molnar B.
Ultra-high-speed digital slide scanners: a new generation for digital pathology |
| | | | |
| | | | Nap M.
Digital histology in routine sign-out |
| | | | |
| | | | Miller K.
Quantitative and digital immunohistochemistry: new opportunities |
| | | | |
| | | | Varga V.S.
Fluorescence scanning microscopy for automated, digital FISH and multispectral quantification |
| | | | |
| | | | Yagi Y.
3-Dimensional applications of digital pathology |
| | | | |
| |
14:30 - 17:00
--DERMATOPATHOLOGY - PITFALLS IN DERMATOPATHOLOGY | | | | | Demirkesen C.
1nd Case Presentation |
| | | | |
| |
17:30 - 19:00
--DERMATOPATHOLOGY - CUTANEOUS MELANOMA: CHALLENGES IN DIAGNOSIS AND REPORTING | | | | | Cook M.
Important criteria for diagnosis and prognosis of melanoma |
| | | | |
| | | | Batistatou A.
Melanoma histopathology report: proposal for a standardized terminology |
| | | | |
| | | | Gokoz O.
Interobserver variability in the interpretation of histopathological melanoma features: results from a SWG survey |
| | | | |
| | | | Massi D.
Conclusive remarks |
| | | | |
| |
|
| | | | |
| | | | | VASARI | 08:30 - 12:00
--ORAL PRESENTATIONS - PEDIATRIC AND PERINATAL PATHOLOGY - MOLECULAR PATHOLOGY | | | | | Berrebi D.
Calretinin immunohistochemistry: a simple and efficient tool to diagnose Hirschsprung's disease |
| | | | |
| | | | Fallet-Bianco C.
Fetal brain tumours |
| | | | |
| | | | Yacoubi Tahar M.
FISH on extracted nuclei from formalin fixed and paraffin embedded tissues for the diagnosis of chromosomal aneuploidies in malformed fetuses |
| | | | |
| | | | Khong Y.
Placental hemosiderosis: relation to adverse obstetric events and neonatal outcome |
| | | | |
| | | | Kobos J.
Potential prognostic importance of MCM2 protein in chosen solid tumour in children. A preliminary study |
| | | | |
| | | | Ngan B.
Challenges in the diagnosis of malignant primitive tumours of pediatric nasal cavity and sinuses (MPTPNCS). A review of 3 cases |
| | | | |
| | | | Lunardi F.
Chronic lower respiratory disorders in children: high frequency of viral genomes in nasal-wash and bronchoalveolar lavage |
| | | | |
| | | | M.Osterheld
Right-sided diaphragmatic eventration: a rare cause of non-immune hydrops fetalis |
| | | | |
| | | | Yacoubi Tahar M.
Amniotic band disruption complex: a fetopathological study of 7 cases |
| | | | |
| | | | Ohgaki H.
IDH1 mutations in gliomas |
| | | | |
| | | | Haybaeck J.
Lymphotoxin-driven hepatocellular cancer |
| | | | |
| | | | Romagosa Pérez-P C.
New genes related to oncogenic senescence in human cancer |
| | | | |
| | | | Mansukhani Mohandas M.
Performance characteristics of a microRNA based assay to distinguish mesothelioma from adenocarcinoma |
| | | | |
| | | | Conti S.
Preliminary data of a molecular genetic approach to receptor tyrosine kinase family gene EGFR in thymic epithelial tumours (TET) |
| | | | |
| | | | Kothmaier H.
Impacts: planning a European initiative for standardized protein analysis of archival clinical tissues |
| | | | |
| |
14:30 - 17:00
--ORAL PRESENTATIONS - HEAD AND NECK PATHOLOGY | | | | | Spaltro A. Ambrosini
CDc20 immunohistochemical expression is associated with aggressive behavior in squamous cell carcinoma of the oral cavity |
| | | | |
| | | | Andrejevic-Blant S.
Prognostic value of histological predictors in squamous cell carcinoma of the oral cavity |
| | | | |
| | | | Soluk Tekkesin M.
A 37 year retrospective analysis of odontogenic tumours |
| | | | |
| | | | Losito N.
Sclerosing polycystic adenosis of parotid gland with in situ duct carcinoma |
| | | | |
| | | | Kosmehl H.
EGFR and downstream mutations in salivary gland carcinomas |
| | | | |
| | | | Skalova A.
Acinic cell carcinoma with high-grade transformation. A report of 13 cases with immunohistochemical study and analysis of TP53 and HER-2/NEU genes |
| | | | |
| | | | Speel M.E.
Chromosome stability in tonsillar squamous cell carcinoma is associated with HPV and a favorable prognosis |
| | | | |
| | | | Wang Yiyao B.
CTLA-4, IL17A/B/C/D/E/F, PLZF, CD27, FOXP3, RORgammaT and CD70 expression in mucosal melanoma of head and neck |
| | | | |
| | | | Sarioglu S.
Inter-observer reliability for laryngeal preneoplastic lesions |
| | | | |
| | | | Krstulja M.
Synchronization of epithelial and stromal cell proliferation in early glottic cancer |
| | | | |
| | | | Speel M.E.
Aneuploidy detection by DNA image cytometry and fish recognizes progressive premalignant head and neck lesions |
| | | | |
| | | | Altinel D.
Documentation of the sarcomatoid carcinomas of the upper aero digestive tract (5 cases) |
| | | | |
| | | | Michailidi C.
FAK and C-SRC expression in human benign and malignant thyroid lesions |
| | | | |
| | | | Emami S.
Helicobacter pylori colonization in patients with and without chronic sinusitis |
| | | | |
| |
17:30 - 19:00
--ORAL PRESENTATIONS - IT IN PATHOLOGY - MISCELLANEOUS | | | | | Furuya K.
Radiologic-pathologic correlation: novel developments in the way pathologists incorporate multimodal imaging findings into pathology |
| | | | |
| | | | Konsti J.
Texture classifiers for breast cancer outcome prediction |
| | | | |
| | | | Roux L.
A cognitive approach to microscopy analysis applied to automatic breast cancer grading |
| | | | |
| | | | Lundin M.
Arrangement of large scale web slide seminars. Experiences from the ECP 2007 and ECP 2009 |
| | | | |
| | | | Dobson L.
Computer-aided image analysis: expanding the boundaries of digital pathology |
| | | | |
| | | | Lundin J.
Development of an online image analysis platform for digital whole slide speCIMEN |
| | | | |
| | | | Tutac Eunice A.
Knowledge modeling of breast cancer grading using OWL-DL formalism |
| | | | |
| | | | Kolatt T.
The correlation between nuclear size and protein expression level of prognostic and predictive biomarkers in breast carcinoma by computer assisted technology |
| | | | |
| | | | Khong Y.
How much of diagnostic pathology research is not formally funded? |
| | | | |
| |
|
| | | | |
| | | | | ARNOLFO | 08:30 - 12:00
--ELECTRON MICROSCOPY & INFECTIOUS DISEASES PATHOLOGY - THE CONTINUING VALUE OF EM IN INFECTIOUS DISEASE PATHOLOGY | | | | | Manor Y.
Electron microscopy as a complementary rapid viral diagnostic tool in the environment of biomolecular diagnostic methods |
| | | | |
| | | | Zinserling V.
Electron microscopically studies of fungal diseases |
| | | | |
| | | | Bonshek R.
Ophthalmic microsporidial infection - Emerging pathogen or poor detection? |
| | | | |
| | | | Bannert N.
Fast and furious - EM in virus diagnostic and pathogen research |
| | | | |
| | | | van den Bergh Weerman M.
Ultrastructural diagnoses of morbus Whipple |
| | | | |
| | | | Hyatt A.
One world", "one health", "one microscopy": the need for an international diagnostic network |
| | | | |
| | | | Schroeder J.A.
Remote electron microscopy for diagnostic pathology |
| | | | |
| |
14:30 - 17:00
--ELECTRON MICROSCOPY - CURRENT DIAGNOSTIC APPLICATIONS OF ELECTRON MICROSCOPY - ESP ELECTRON MICROSCOPY WG AND SOCIETY FOR ULTRASTRUCTURAL PATHOLOGY JOINT SESSION | | | | | Lloreta Trull J.
Introductory remarks |
| | | | |
| | | | Kyriacou K.
Main applications of electron microscopy in muscle pathology |
| | | | |
| | | | Sirvanci S.
Electron microscopy in ciliary disorders |
| | | | |
| | | | Turbat-Herrera E.A.
Main applications of electron microscopy in cytopathology |
| | | | |
| | | | Fernández-Figueras M.T.
Electron microscopy in non-neoplastic skin diseases |
| | | | |
| | | | Herrera G.
The crucial role of ultrastructural evaluation in proximal tubular pathology |
| | | | |
| | | | Franchi A.
Closing remarks |
| | | | |
| |
17:30 - 19:00
--LEZIONE DI ANATOMIA - MODALITÀ DI STUDIO DEL CUORE NELLA MORTE CARDIACA IMPROVVISA | | | | | Thiene G.
Linee guida per l'indagine autoptica |
| | | | |
| | | | Basso C.
Videodimostrazione |
| | | | |
| |
|
| | | | |
| | | | | BOTTICELLI | 08:30 - 12:00
--LANGERHANS CELL HYSTIOCYTOSIS - LANGERHANS CELL HISTIOCYTOSIS (LCH) | | | | | Facchetti F.
Langerhans cell histiocytosis |
| | | | |
| | | | Delprat C.
Recent advances in the pathogenesis of LCH |
| | | | |
| | | | Aricò M.
Clinical features and treatment of systemic LCH |
| | | | |
| | | | Ruco L.
Pulmonary Langerhans cell histiocytosis (LCH): pathologic features and differential diagnosis |
| | | | |
| | | | Poletti V.
Pulmonary Langerhans' cell histiocytosis |
| | | | |
| |
14:30 - 17:00
--PULMONARY AND CYTOPATHOLOGY - LUNG AND PLEURAL TUMOURS: CYTOLOGIC - HISTOLOGIC APPROACH AND ANCILLARY TECHNIQUES | | | | | Paakko P.
Common neoplasms of the lung and morphologic variants |
| | | | |
| | | | Thivolet-Bejui F.
Uncommon neoplasms of the lung: main pitfalls |
| | | | |
| | | | Praet M.
Pleural tumours and mimics: a practical approach |
| | | | |
| | | | Murer B.
Metastatic tumours of the lung and pleura |
| | | | |
| | | | Schmitt F.
Ancillary techniques on lung cytology |
| | | | |
| |
17:30 - 19:00
MOLECULAR PATHOLOGY - MOLECULAR PATHOLOGY BUSINESS MEETING | | | | | Bevilacqua G.
Introduzione |
| | | | |
| |
|
| | | | |
| | | | | BRUNELLESCHI | 08:30 - 10:00
--IT IN PATHOLOGY - PART 1 - VIRTUAL SLIDES IN DIAGNOSTIC PATHOLOGY | | | | | Kayser K.
Application of virtual slides in Histopathology |
| | | | |
| | | | Dietel M.
Experiences in routine and research application of virtual slides |
| | | | |
| | | | van Diest P.J.
The digital pathology archive: the UMCU initiative |
| | | | |
| | | | Yagi Y.
3D imaging with WSI (virtual slide) |
| | | | |
| | | | Yagi Y.
Network/data structure for WSI clinical usage |
| | | | |
| |
11:00 - 12:00
--IT IN PATHOLOGY - PART 2 - VIRTUAL MICROSCOPY IN RESEARCH AND MOLECULAR BIOLOGY | | | | | Kayser G.
Automated Prescreening in virtual Pathology |
| | | | |
| | | | Metze K.
Changes of texture features due to image compression |
| | | | |
| | | | Gombas P.
Effect of digital microscopy technology on surgical pathology informatics |
| | | | |
| | | | Montironi R.
Automated decision algorithms in prostate cancer |
| | | | |
| | | | Molnár B.
Digitalization of histology: HE, IH, FISH mutations |
| | | | |
| |
14:30 - 17:00
--IT IN PATHOLOGY - TELEMEDICINE AND TELEMEDICAL NETWORKS | | | | | Oberholzer M.
Telemedicine with campus medicus in rural and industrialized countries |
| | | | |
| | | | Garcia Rojo M.
Two years experience in the telepathology network of Castilla-La Mancha |
| | | | |
| | | | Seiwerth S.
Server-based teleconsultation in lung pathology |
| | | | |
| | | | Tsuchihashi Y.
Use of virtual slides in Japan, from education to telepathology |
| | | | |
| | | | Slodkowska J.
Telepathology applications in difficult-to-diagnose lung diseases |
| | | | |
| | | | Helliwell T.
Cancer histopathology datasets - Development and implementation |
| | | | |
| | | | Schmid J.
Pathology workflow and the integration of image analysis |
| | | | |
| | | | Boon M.
Imaging paraffin sections using the coagulant fixative BoonFix |
| | | | |
| | | | Amaral-Mendes J.J.
Biological effects of low-level exposure to ionizing radiation, health risks and clinical consequences |
| | | | |
| |
17:30 - 19:00
--IT IN PATHOLOGY - VIRTUAL MICROSCOPY IN EDUCATION AND TRAINING | | | | | Haroske G.W.
From text to information - How could pathologists contribute to free flow of medical information |
| | | | |
| | | | Batistatou A.
Medicine and humanities in the era of electronic information exchange |
| | | | |
| | | | Fónyad L.
Digital slide and virtual microscope based graduate and postgraduate education program: a 3 year experience |
| | | | |
| | | | Szymas J.
Four years experiences teaching pathology with the WebMicroscopeto dental students |
| | | | |
| | | | Kiss A.
Postgradual training and digital case teleseminars |
| | | | |
| | | | Miller K.
Quality control for IHC & ISH: the challenges ahead |
| | | | |
| |
|
| | | | |
| | | | | CIMABUE | 08:30 - 10:00
--CITOPATOLOGIA MAMMARIA | | | | | Simone G.
Linee guida della FNC della mammella: proposta SIAPEC |
| | | | |
| | | | Palombini L.
Citologia FNC il vecchio ed il nuovo: Adelante Pedro, con judicio! |
| | | | |
| | | | Di Bonito L., Zanconati F.
Correlazione cito istologica in patologia mammaria |
| | | | |
| | | | Fiaccavento S.
Citologia nei casi indeterminati (C3) e immunicitochimica: possiamo migliorare questa classe diagnostica? |
| | | | |
| | | | Saragoni L.
FNC mammaria e core biopsy: strumenti complementari o alternative? |
| | | | |
| | | | Casadio C.
FNC e citologia in strato sottile: un nuovo strumento disponibile o un rischio inutile? - Strumento disponibile |
| | | | |
| | | | Fulciniti F.
FNC e citologia in strato sottile: un nuovo strumento disponibile o un rischio inutile? - Un inutile rischio |
| | | | |
| |
11:00 - 12:00
--CITOLOGIA TIROIDEA | | | | | Nardi F.
Classificazione citologica delle lesioni tiroidee |
| | | | |
| | | | Fadda G.
Citologia tiroidea in fase liquida |
| | | | |
| | | | Papotti M.
Immunocitochimica nella citologia tiroidea |
| | | | |
| |
13:00 - 14:30
--SIMPOSIO SATELLITE OLYMPUS - ESPERIENZE E FUTURI SVILUPPI DELLA PROCESSAZIONE RAPIDA E CONTINUA E DELL'INCLUSIONE AUTOMATICA FINO AL VETRINO DIGITALE | | | | | Kayser G.
Esperienze con la processazione rapida |
| | | | |
| | | | Cavazzana A.
L'inclusione automatica |
| | | | |
| | | | Pisa R.
La processazione rapida e continua |
| | | | |
| |
14:30 - 17:00
--HPV SESSION - USE OF MOLECULAR BIOLOGY AND GENOMICS IN THE HPV LOWER GENITAL TRACT INFECTIONS | | | | | Carozzi F.
Molecolar biology and biomarkers: an overview |
| | | | |
| | | | Dalla Palma P.
HPV DNA testing in organised primary screening |
| | | | |
| | | | Bondi A.
May detection of p16INK4A modify diagnosis criteria's of ASC-US & L-SIL? |
| | | | |
| | | | Schmidt D.
p16INK4A significant increase of accuracy in diagnosing high-grade CIN |
| | | | |
| |
17:30 - 19:00
--CITOLOGIA URINARIA | | | | | D.Beccati
Introduzione neoplasie vescicali |
| | | | |
| | | | Dalla Palma P.
Refertazione citologica unificata |
| | | | |
| | | | Bollito E.
Applicazione della FISH alla citologia urinaria |
| | | | |
| | | | Lapini A.
Il parere dell'urologo sull'efficacia della citologia urinaria |
| | | | |
| |
|
| | | | |
| | | | | DELLA-ROBBIA | 08:30 - 12:00
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: CYTOPATHOLOGY CYTOPATHOLOGY OF THE BREAST | | |
14:30 - 17:00
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: HEAD AND NECK PATHOLOGY | | |
17:30 - 19:00
--ORAL PRESENTATIONS - BREAST PATHOLOGY | | | | | Habashy Onsy H.
Oestrogen receptor-positive breast cancer: identification of significant prognostic patho-biological subgroups |
| | | | |
| | | | Tommaso L. Di
Pathological features of nodal micrometastases predict distant failure in patients affected by breast cancer |
| | | | |
| | | | Carvalho S.
"Piking" the right isoform for breast cancer progression |
| | | | |
| | | | Ichihara S.
Pure intracystic papillary carcinoma of the breast with spread to the ipsilateral intrammary lymph node five years after needling procedure |
| | | | |
| | | | Elsberger B.
Survival analysis of most expressed SRC kinase family members (SKFMs) in human breast carcinoma |
| | | | |
| | | | Miller K.
The UK NEQAS online auditing system for breast cancer predictive markers |
| | | | |
| | | | Peston D.
Intra-operative assessment of sentinel node biopsy for breast carcinoma using OSNA technique. The Charing Cross experience |
| | | | |
| | | | Ellis I. O.
The need for a biological grading system and its relationship to the current nottingham histological grading system (NGS) |
| | | | |
| | | | Busmanis I.
Recurrent phyllodes tumours |
| | | | |
| |
|
| | | | |
| | | | | GIOTTO | 08:30 - 10:00
--PATOLOGIA POLMONARE | | | | | Nappi O.
Dove siamo: il nuovo TNM 2009 |
| | | | |
| | | | Fontanini G.
Dove stiamo andando: marcatori molecolari prognostici e predittivi |
| | | | |
| | | | Rossi G.
Il carcinoma a grandi cellule: realtà o mito? |
| | | | |
| | | | Murer B.
Carcinomi polmonari e esposizione all'asbesto |
| | | | |
| |
11:00 - 12:00
--SESSIONE DI COMUNICAZIONI LIBERE | | | | | Barberis M.
Infezione da poliovirus nel timo di pazienti miastenici: autoimmunità virus-mediata nella miastenia grave? |
| | | | |
| | | | Franco R.
Alterazioni citogenetiche dei geni bcl10 e MALT1 e le infezioni da Chlamydia psittaci nel linfomi degli annessi oculari di tipo MALT |
| | | | |
| | | | Barberis M.
Persistenza e attivazione dell'Epstein-Barr virus nel timo con iperplasia o regressione di pazienti con miastenia grave |
| | | | |
| | | | Vellone V.G.
Differenze nella risposta alla radio-chemioterapia dei carcinomi squamosi e non-squamosi della cervice uterina |
| | | | |
| | | | Vellone V.G.
Espressione della survivina nelle biopsie pre-trattamento di pazienti sottoposte a radio-chemioterapia neoadiuvante per carcinoma della cervice uterina e correlazioni con la risposta patologica sui prelievi chirurgici post trattamento |
| | | | |
| | | | Mannone T.
Adenoma epatico della placenta. Descrizione di un caso e revisione della letteratura |
| | | | |
| | | | Mannone T.
Carcinoma scarsamente differenziato misto della cervice uterina (carcinoma neuroendocrino ed adenocarcinoma di tipo intestinale) |
| | | | |
| | | | Schiavo N.
Adenocarcinoma mucinoso della vagina insorto su un'area di metaplasia intestinale, in una fistola uretro-vaginale. Descrizione di un caso |
| | | | |
| | | | Altavilla A.
Carcinoma indifferenziato a piccole cellule del collo dell'utero, ad alto potenziale di malignità, in una giovane donna di 23 anni: descrizione di un caso e revisione della letteratura |
| | | | |
| | | | Pignanelli S.
Le infezioni genitali da C. trachomatis in giovani donne asintomatiche |
| | | | |
| |
12:00 - 12:30
--SIMPOSIO SATELLITE MERCK SERONO - DIAGNOSI E TERAPIA PERSONALIZZATA NEL TUMORE DEL COLON-RETTO: IL RUOLO DI CETUXIMAB | | | | | Normanno N.
Diagnosi e biomarcatori: a che punto siamo? |
| | | | |
| | | | Di Costanzo F.
Selezione del paziente e appropriatezza terapeutica con cetuximab |
| | | | |
| |
17:30 - 19:00
--ENDOMETRIO DISFUNZIONALE | | | | | Scarselli G.
Aspetti clinici delle endometriopatie disfunzionali |
| | | | |
| | | | Buccoliero A.M.
Le possibilità della diagnosi citologica |
| | | | |
| | | | Resta L.
I principi della diagnosi istologica |
| | | | |
| | | | Zannoni G.F.
Le problematiche della biopsia isteroscopia |
| | | | |
| |
|
| | | | |
| | | | | LEONARDO | 08:30 - 12:00
--NEPHROPATHOLOGY - RENAL PATHOLOGY WITHOUT ELECTRON AND IMMUNOFLUORESCENCE MICROCOPY: A DEAD END STREET | | |
13:00 - 14:30
--SATELLITE SYMPOSIUM ABBOTT MOLECULAR, ABBOTT ITALY INTRODUCING ADVANCES FOR MOLECULAR PATHOLOGY | | | | | Martin V.
The clinical utility of EGFR FISH in patient selection for colorectal and lung cancer therapies |
| | | | |
| | | | Pauwels P.
The relevance of FISH in the diagnostics of soft tissue tumours |
| | | | |
| | | | Massi D.
FISH as an innovative tool aiding melanoma diagnosis |
| | | | |
| |
14:30 - 17:00
--NEPHROPATHOLOGY - NEW INSIGHTS INTO THE PATHOGENESIS OF RENAL DISEASES | | | | | Kain R.
Molecular mimicry in pauci-immune focal necrotizing glomerulonephritis |
| | | | |
| | | | Huber T.
Molecular pathology of the glomerular slit diaphragm and proteinuria |
| | | | |
| | | | Romagnani P.
Towards the identification of a "renopoietic system" |
| | | | |
| | | | Susztak K.
The pathogenic role of notch activation in podocytes |
| | | | |
| |
17:30 - 19:00
--ORAL PRESENTATIONS - PULMONARY PATHOLOGY - MISCELLANEOUS | | | | | Hofman V.
Cytopathological cross validation of preoperative circulating tumour cell detection in patients with non small cell lung carcinoma |
| | | | |
| | | | E.Kogan
Molecular events at early and late stages of idiopathic pulmonary fibrosis (IPF) |
| | | | |
| | | | M.Samsonova
Pathologic variants of COPD |
| | | | |
| | | | Souza Da Costa P.
Refractory remodelling of the microenvironment by abnormal type v collagen, apoptosis and immune response in non small cell lung cancer |
| | | | |
| | | | Fassan M.
Somatostatin receptor type 2 in bronchopulmonary carcinoids: new clinical and diagnostic implications |
| | | | |
| | | | Samsonova M.
Systemic amyloidosis: a case report |
| | | | |
| | | | Capelozzi V.L.
Immunophenotyping study in patients with pulmonary and extra-pulmonary sarcoidosis |
| | | | |
| | | | Capelozzi V.L.
Collagen and elastic fibers evaluation in granulomatosis lung diseases |
| | | | |
| | | | Serio G.
Microarray comparative genomic hybridization analysis in malignant peritoneal mesothelioma |
| | | | |
| |
|
| | | | |
| | | | | MASACCIO | 11:00 - 12:00
--SESSIONE DI COMUNICAZIONI LIBERE | | | | | Felicioni L.
Mutazioni del gene KRAS in pazienti trattati con inibitori tirosino-chinasici: implicazioni cliniche delle mutazioni evidenziate con metodiche sensibili in sottopopolazioni cellulari |
| | | | |
| | | | Bellezza G.
Espressione immunoistochimica di IMP3 nei carcinomi non a piccole cellule del polmone (NSCLC) |
| | | | |
| | | | D.Mizio
Ruolo dell'istologia della placca carotidea nella predittività dell'infarto miocardico acuto |
| | | | |
| | | | Colella R.
Analisi immunoistochimica dell'espressione di EMMPRIN/CD147 nel carcinoma papillare della tiroide: un marcatore di metastasi linfonodale? |
| | | | |
| | | | Crisman G.
Lipomi e lipomatosi del distretto cervico-facciale |
| | | | |
| | | | Fondi C.
Carcinoma mucoepidermoide primitivo linfonodale |
| | | | |
| | | | Crisman G.
Un caso di mesenchimoma orale benigno e revisione della letteratura |
| | | | |
| |
14:30 - 17:00
PATOLOGIE OLTRE FRONTIERA | | |
17:30 - 19:00
--BIOLOGIA MOLECOLARE | | | | | Castiglione F.
Protocollo Qualità |
| | | | |
| | | | Marchetti A.
Marcatori predittivi di risposta ai farmaci anti-EGFR |
| | | | |
| | | | Inghirami G.
L'apporto dell'analisi molecolare nella diagnostica dei linfomi |
| | | | |
| | | | Barbareschi M.
Citopatologia molecolare. Il modello del carcinoma tiroideo |
| | | | |
| | | | Bosari S.
Nuovi marcatori molecolari nella diagnostica del mesotelioma |
| | | | |
| |
|
| | | | |
| | | | | MICHELANGELO | 08:30 - 12:00
--SOFT TISSUE TUMOURS - SOFT TISSUE TUMOURS SLIDE SEMINAR | | |
14:30 - 17:00
--SOFT TISSUE TUMOURS - RECENT ADVANCES IN BONE AND SOFT TISSUE PATHOLOGY | | | | | Alava E. de
The clinical relevance of molecular genetics in soft tissue sarcomas | |
| | | | |
| | | | Hogendoorn P.
Challenging giant cell lesions of bone and soft tissues | |
| | | | |
| | | | Antonescu C.
Pediatric and syndromic GIST: from morphology to genetics | |
| | | | |
| | | | Fletcher C.D.M.
Recently characterized soft tissue tumours that bring biologic insight | |
| | | | |
| |
17:30 - 19:00
--SOFT TISSUE TUMOURS - ORGAN RELATED MESENCHYMAL TUMOURS | | |
|
| | | | |
| | | | | RAFFAELLO | 08:30 - 12:00
--ENDOCRINE PATHOLOGY - POORLY DIFFERENTIATED ENDOCRINE CARCINOMA: SMALL CELL, LARGE CELL AND OTHER ENTITIES | | | | | Cerroni L.
Merkel cell carcinoma |
| | | | |
| | | | Papotti M.
Poorly differentiated neuroendocrine carcinomas of the lung |
| | | | |
| | | | Jiang S.-X.
Gastric large cell neuroendocrine carcinomas: a distinct clinicopathological entity |
| | | | |
| |
13:00 - 14:30
--SATELLITE SYMPOSIUM A. MENARINI DIAGNOSTICS - HOW TO REDUCE HUMAN ERROR IN SURGICAL PATHOLOGY? | | | | | Doglioni C.
Expert systems in histopathological diagnosis |
| | | | |
| | | | Chilosi M.
Bio-technologies as diagnostic support |
| | | | |
| |
14:30 - 17:00
--ENDOCRINE PATHOLOGY - DIFFICULT/UNUSUAL ENDOCRINE PATHOLOGY DIAGNOSES IN ROUTINE PATHOLOGY | | |
17:30 - 19:00
--ENDOCRINE PATHOLOGY - GENETICS OF GI ENDOCRINE TUMOURS | | | | | Couvelard A.
Gene profiling |
| | | | |
| |
|
| | | | |
| | | | | VASARI | 08:30 - 12:00
--ORAL PRESENTATIONS - DIGESTIVE DISEASES PATHOLOGY | | | | | Gligorijevic Velja J.
CD34 in cirrhotic liver - Reliance to dedifferentiation |
| | | | |
| | | | Guettier C.
Chemical imaging of Liver Steatosis Chemical imaging of Liver Steatosis using synchrotron IR microspectroscopy |
| | | | |
| | | | Le Naour F.
Chemical imaging of liver steatosis using synchrotron infrared microspectroscopy |
| | | | |
| | | | Ghigna M.
Gamma smooth muscle actin: a marker of epithelial-mesenchymal transition for hepatocellular carcinoma? |
| | | | |
| | | | Riener M.
GOLPH2 expression in liver tumours and its value as a serum marker for hepatocellular carcinomas |
| | | | |
| | | | Mahmoud M. Akl
Localization of schistosoma mansoni antigen confirms the frequent coexistence of hepatic schistosomiasis with chronic viral hepatitis C. An immunohistochemical study |
| | | | |
| | | | Su C.
Human herpesvirus type 8 in patients with cirrhosis independent of thrombocytopenia |
| | | | |
| | | | Gurbuz Y.
Kupffer cells in non alcoholic steatohepatitis (NASH), hepatosteatosis (HS) and normal liver |
| | | | |
| | | | Weber A.
Mcl-1 is important for integrity and survival of hepatocytes |
| | | | |
| | | | Nosseir Mostafa Fahmy M.
Oxidative stress in hepatitis C virus infection and associated liver cirrhosis |
| | | | |
| | | | Fresno Forcelledo Florentino M.
anti COL11 IS a useful marker of infiltrating pancreatic cancer |
| | | | |
| | | | Cataldo I.
Expression pattern of claudins 3 and 5 distinguishes intestinal from pancreaticobiliary ampulla of Vater carcinoma |
| | | | |
| | | | Handra-Luca A.
Pathological and clinical roles of mTOR in pancreatic ductal adeno carcinomas |
| | | | |
| | | | Serra S.
VHL expression in pancreatic adenocarcinomas |
| | | | |
| | | | Theocharis S.
Clinical significance of ephrin receptors -A2, -A4, -A5 and -A7 expression in pancreatic adenocarcinoma |
| | | | |
| | | | Mameri S.
Morphological and immunohistochemical study of 165 gallbladders and review of literature |
| | | | |
| |
14:30 - 17:00
--ORAL PRESENTATIONS - UROLOGICAL PATHOLOGY | | | | | Van Der Kwast H.T.
Impact of sub-stage on the clinical outcome of pT1 bladder cancer |
| | | | |
| | | | Bravou V.
Altered ezrin expression in urothelial bladder tumours |
| | | | |
| | | | Levidou G.
D-type cyclins in superficial and muscle-invasive bladder urothelial carcinoma: correlation with clinicopathological data and prognostic significance |
| | | | |
| | | | Segala D.
Expression of GATA-3 among renal cell and urothelial neoplasms |
| | | | |
| | | | Cai T.
Loss of heterozygosity on chromosome 18 as a prognostic indicator of urothelial bladder cancer |
| | | | |
| | | | Hammam Ali O.
The role of TGF-beta-1 protein and TGF-beta-R-1 receptor in immune escape mechanism in bladder cancer |
| | | | |
| | | | Hammam Ali O.
Role of telomerase and sFas in pathogenesis of various bladder lesions associated with schistosomiasis |
| | | | |
| | | | Botelho C.M.
Schistosoma haematobium total antigen induces dysplasia and inflammation on the urothelium of CD-1 mice |
| | | | |
| | | | Trpkov K.
Prostatectomy and preoperative findings in patients with prostate cancer (PCA) involving < 1% of gland volume |
| | | | |
| | | | Sorrentino C.
The lack of IL-7 and BAFF/BLyS gene expression in prostate cancer as a mechanism of tumour escape from immuno-surveillance |
| | | | |
| | | | Walsh T.
Elevated expression of adiponectin receptor 2 is associated with adverse outcome in prostate cancer |
| | | | |
| | | | Kristiansen G.
Identification and validation of differentially expressed miRNAs of prostate cancer |
| | | | |
| | | | Kozakowski N.
Influence of hormonal deprivation therapy on relevant chemotherapy targets in prostate cancer |
| | | | |
| | | | Markova A.
Stromal-parenchymal interactions and MMP2, MMP13 and TIMP1 in prostate intraepithelial neoplasia and prostate cancer |
| | | | |
| | | | Baydar Ertoy D.
Analysis of penile condylomas and dysplasia |
| | | | |
| |
17:30 - 19:00
--ORAL PRESENTATIONS - NEPHROPATHOLOGY | | | | | Canaud G.
Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS) and risk of recurrence after transplantation |
| | | | |
| | | | Koleganova N.
High salt intake and oxidative stress in the kidney. The role of fetal programming |
| | | | |
| | | | Koleganova N.
High salt intake in pregnancy alters maturation of glomeruli in the rat offspring |
| | | | |
| | | | Sarioglu S.
Intensity, mean and total optical density of immune deposits in renal diseases |
| | | | |
| | | | Ferlicot S.
Non-heart beating donors are associated with a major and early increase in renal graft fibrosis quantified by an automatized image software analysis |
| | | | |
| | | | Liapis G.
The significance of peritubular capillary basement membrane laminations in native and transplant kidneys |
| | | | |
| | | | Servais A.
Unusual evolution of type II membranoproliferative glomerulonephritis associated with factor I mutation |
| | | | |
| | | | Goldberg C.J.
Deceased donor kidney evaluation. The turning point |
| | | | |
| | | | Petrusevska K.G.
Immunohistochemical study of the inflammatory infiltrate and the proliferative index in the tubulointerstitium in human glomerulonephritis |
| | | | |
| |
|
| | | | |
| | | | | ARNOLFO | 08:30 - 10:00
--NOMENCLATORI E CODIFICHE DIAGNOSTICHE | | | | | Crucitti P.
NAP: il nuovo nomenclatore per le Anatomie Patologiche Italiane. Stato di avanzamento e previsione d'uso |
| | | | |
| | | | Francescutti C.
Manutenzione e garanzia dei sistemi condivisi: il Portale delle Classificazioni |
| | | | |
| | | | Ferretti S.
Opportunità e prospettive della codifica automatica e assistita in Anatomia Patologica: il sistema Find & Code |
| | | | |
| | | | Gongolo F.
La preparazione dell'ICD 11: il contributo dell'Italia e la collaborazione con l'OMS |
| | | | |
| |
10:30 - 12:30
--APPLICAZIONI DELLE NUOVE TECNOLOGIE IN UROPATOLOGIA -IN MEMORIA DI DONALD F. GLEASON | | | | | Gobbo S.
Citogenetica in fluorescenza FISH, CGE e tumori renali |
| | | | |
| | | | Bollito E.
Citologia urinaria e FISH |
| | | | |
| | | | Zaffaroni N.
mi-RNA nelle neoplasie del tratto urogenitale |
| | | | |
| | | | Patriarca C.
Citofluorimetria nelle indagini sulla fertilità maschile |
| | | | |
| | | | Scarpelli M.
Approcci diagnostici (biomolecolari ed immunoistochimici) nel carcinoma del surrene |
| | | | |
| | | | Staibano S.
Nuovi marcatori immunoistochimici e molecolari predittivi nel carcinoma prostatico |
| | | | |
| |
12:30 - 14:00
--SLIDE SEMINAR: DIAGNOSI DIFFICILI IN DERMATOPATOLOGIA - GRUPPO ITALIANO DI STUDIO DI DERMATOPATOLOGIA (GISD) DELLA SIAPEC-IAP | | |
|
| | | | |
| | | | | BOTTICELLI | 08:30 - 11:30
--MOLECULAR PATHOLOGY - MOLECULAR PATHOLOGY SYMPOSIUM | | | | | van Krieken J.H.J.M.
KRAS gene in colorectal carcinoma |
| | | | |
| | | | Turashvili G.
Are columnar cell lesions the earliest step in molecular evolution of breast cancer? |
| | | | |
| | | | Quintanilla-Martinez L.
Cyclin D1 in B-cell neoplasms: a combined in vivo and in vitro approach |
| | | | |
| | | | Vecchione A.
Role of microRNAs in molecular diagnosis of cancer |
| | | | |
| | | | Gorkiewicz G.
Analysis of the human gut microbiota by massively parallel DNA pyrosequencing |
| | | | |
| |
11:30 - 13:30
--SESSIONE DI COMUNICAZIONI LIBERE | | | | | Di Cristofano C.
La metodica fluorescence in situ hybridization (FISH) nelle lesione melanocitarie: risultati preliminari |
| | | | |
| | | | Cartaginese F.
Significato prognostico dell'espressione immunoistochimica di IMP- 3 nel melanoma cutaneo |
| | | | |
| | | | Senatore S.A.
ll sarcoma di Kaposi: un modello significativo per lo studio delle correlazioni clinico-patologiche nei tumori |
| | | | |
| | | | Maio V.
Tecniche di imaging non lineare per lo studio di patologie del collagene |
| | | | |
| | | | Paglierani M.
Lesioni melanocitarie cutanee: identificazione dei markers RREB1, MYB, CCND1 e del cromosoma 6 mediante analisi FISH su sezioni di tessuto incluso in paraffina |
| | | | |
| | | | Cartaginese F.
Espressione della proteina IMP3 nei carcinomi mammari "tripli-negativi" |
| | | | |
| | | | Parisi A.
Diagnosi di radial scar su agobiopsia mediante mammotome: correlazioni con successiva biopsia escissionale |
| | | | |
| | | | Giannatiempo R.
Il potenziale ruolo del recettore delle chemiochine cxcr4 nella patologia mammaria: studio con tissue microarray progressivo |
| | | | |
| | | | Ieni A.
Determinazione di Her-2 nel carcinoma mammario: verso un percorso condiviso in Sicilia |
| | | | |
| | | | Giannatiempo R.
Ibridazione in situ con sali d'argento (S.I.S.H.): una metodica alternativa per la identificazione dello status genico di Her-2 nel carcinoma della mammella |
| | | | |
| | | | Vergine M.
Valutazione dello status di Her-2/neu nei carcinomi lobulari infiltranti secondo i criteri ASCO/CAP |
| | | | |
| | | | Lonardi S.
Claudina 4, un utile marcatore nella diagnosi differenziale tra carcinoma e mesotelioma su materiale citologico |
| | | | |
| | | | Brunello E.
Cito-immunoespressione di E-caderina su agoaspirato da carcinoma della mammella nella selezione di appropriata terapia IORT |
| | | | |
| | | | Toraldo M.
Confronto tra citologia aspirativa con ago sottile e parametri ecografici nei noduli tiroidei: uno score ecografico per selezionare i noduli da sottoporre a FNA |
| | | | |
| | | | Quarchioni M.
Nuovo test combinato molecolare-morfologico: prospettive di implementazione nello screening del cervicocarcinoma e nella modulazione della terapia |
| | | | |
| | | | Renzulli G.
Ottimizzazione della tecnica di esecuzione dell'ago aspirato tiroideo |
| | | | |
| | | | Spinelli M.
Accuratezza della diagnosi citologica agoaspirativa con ago sottile nel cancro della mammella secondo le Linee Guida Europee e confronto fra casi da screening e casi ad affluenza spontanea |
| | | | |
| |
13:30 - 15:00
--SESSIONE DI COMUNICAZIONI LIBERE | | | | | Gafà R.
Caratterizzazione clinico-patologica e molecolare dei carcinomi colorettali MSI-H identificati mediante screening di popolazione |
| | | | |
| | | | Reggiani Bonetti L.
Micrometastasi linfonodali in pazienti con carcinoma colorettale in stadio I ad evoluzione infausta |
| | | | |
| | | | Cataldo I.
Cistoadenoma biliare dell'ilo epatico |
| | | | |
| | | | Pedica F.
Gastrite acuta flemmonosa indotta da azatrioprina in paziente con malattia di Crohn |
| | | | |
| | | | Reggiani Bonetti L.
Adenomi cancerizzati: rapporto tra fattori istologici di rischio ed evoluzione clinica |
| | | | |
| | | | Ramieri M.T.
Valutazione dello stato di amplificazione di Her-2 nel carcinoma gastrico mediante metodica SISH |
| | | | |
| | | | D'Amuri A.
Metastasi cutanea di cordoma: descrizione di un caso |
| | | | |
| | | | Sanguedolce F.
Teratocarcinoma primitivo del terzo ventricolo simulante un craniofaringioma all'esame intraoperatorio |
| | | | |
| | | | Ghimenton C.
Ependimosarcoma: case report |
| | | | |
| | | | Pecori S.
Qualità e accreditamento del test FISH per la valutazione di Her-2/neu nel carcinoma della mammella |
| | | | |
| | | | Di Marco G.
Bioingegneria medica nel medioevo. Protesi per arto superiore ed arto inferiore. Descrizione e studio di protesi per arto di proprietà del Museo Stibbert di Firenze |
| | | | |
| | | | Segala D.
Amplificazione del gene target Her-2/neu nelle neoplasie renali |
| | | | |
| | | | Segala D.
Accuratezza diagnostica del materiale bioptico su tumori renali |
| | | | |
| | | | Di Marco G.
Linfoma a grandi cellule b primitivo della prostata. Studio istologico ed immunoistochimico di un caso e revisione della letteratura |
| | | | |
| |
|
| | | | |
| | | | | BRUNELLESCHI | 08:30 - 11:30
--ORAL PRESENTATIONS - CARDIOVASCULAR PATHOLOGY - PULMONARY PATHOLOGY | | | | | Wohlschlaeger J.
Ventricular unloading increases 20s proteasome protein expression and restores proteasomal function in a subset of patients |
| | | | |
| | | | Fedrigo M.
C4d immunostaining in the follow-up of cardiac transplantation |
| | | | |
| | | | Metze K.
Computerized texture analysis of histologic sections: comparison of aortas of normotensive and hypertensive patients |
| | | | |
| | | | Castellani C.
Stem cells homing, ventricular remodelling and cytokines profile in an animal model of heart failure |
| | | | |
| | | | Mercado M.
Cardiac variant of Fabry's disease associated to ichthyosis |
| | | | |
| | | | Wohlschlaeger J.
Hemodynamic support by left ventricular assist devices reduces cardiomyocyte DNA content and increases myocardial stem cells in the failing human heart |
| | | | |
| | | | Al-Saad S.
Diverse prognostic roles of AKT isoforms, PTEN and PI3K in tumour epithelial cells and stromal compartment in non-small cell lung cancer |
| | | | |
| | | | Ilie M.
High level of carbonic anhydrase IX (CAIX) in tumour tissue and plasma is associated with non-small cell lung carcinoma (NSCLC) progression and poor survival of patients |
| | | | |
| | | | Ab'Saber Muxfeldt A.
Lymphatic fluctuation in parenchymal remodelling stage of organizing pneumonia, nonspecific interstitial pneumonia and idiopathic pulmonary fibrosis |
| | | | |
| | | | Birukov G.K.
Protective effects of iloprost in cellular and animal models of ventilator-induced lung injury |
| | | | |
| | | | Lunardi F.
Serpin B3 transgenic mice are more susceptible to lung fibrosis and epithelial proliferation |
| | | | |
| | | | Al-Shibli Ibrahim K.
The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma |
| | | | |
| | | | Al-Shibli Ibrahim K.
The prognostic value of intraepithelial and stromal T cells, mast cells and plasma cells in non-small cell lung carcinoma |
| | | | |
| | | | Pereira A. Velosa
Type V collagen nasal tolerance decrease pulmonary collagen mRNA and TGF-beta expression in experimental model of systemic sclerosis |
| | | | |
| | | | Bellevicine C.
UbcH10 may be a useful tool in the prognosis of lung carcinomas |
| | | | |
| |
|
| | | | |
| | | | | CIMABUE | 08:30 - 14:00
--SESSIONE PER TECNICI DI LABORATORIO | | | | | Simonazzi S., Zanin T.
IL FUTURO DELLA FORMAZIONE - Progetto AITIC-FAD: costruzione di un progetto formativo |
| | | | |
| | | | Zanin T.
L'ERRORE E LA RESPONSABILITÀ DEL TECNICO IN ANATOMIA PATOLOGICA - L'errore nel processo di allestimento di un preparato cito-istologico |
| | | | |
| | | | Esposito A.
L'ERRORE E LA RESPONSABILITÀ DEL TECNICO IN ANATOMIA PATOLOGICA - L'HTA e la responsabilità professionale |
| | | | |
| | | | Pizzaferri R.
PREVENZIONE SANITARIA ONCOLOGICA - Il fumo e i suoi danni |
| | | | |
| |
|
| | | | |
| | | | | DELLA-ROBBIA | 08:30 - 11:30
--VIDEOMICROSCOPY TUTORIAL SESSION - MEET THE EXPERT IN: UROPATHOLOGY | | |
|
| | | | |
| | | | | GIOTTO | 08:30 - 10:00
--PATOLOGIA GASTROINTESTINALE E BILIO-PANCREATICA | | | | | Villanacci V.
Coliti da Farmaci e Allergiche |
| | | | |
| | | | Solcia E.
Carcinoma gastrico: identificazione di forme a basso ed alto grado |
| | | | |
| | | | Capelli P.
Tumori endocrini del pancreas: classificazione e criteri applicativi del nuovo TNM |
| | | | |
| | | | Fiorentino M.
Colangiocarcinoma intraepatico: fattori progostici e predittivi molecolari |
| | | | |
| |
10:30 - 12:30
--QUALITÀ E SICUREZZA IN ANATOMIA PATOLOGICA | | | | | Ghirardini A.
Le strategie per la sicurezza dei sistemi sanitari |
| | | | |
| | | | Tartaglia R.
Il processo di gestione del rischio in anatomia patologica: le esperienze della Regione Toscana |
| | | | |
| | | | Fabiano A.
Il servizio di anatomia patologica nel processo diagnostico-assistenziale |
| | | | |
| | | | Santeusanio G.
Organizzazione del servizio di anatomia patologica nell'ottica del risk management |
| | | | |
| |
12:30 - 13:05
--APEFA 2009: EVOLUZIONI DI UN PROGETTO; EVOLUZIONI DI UN GRUPPO DI STUDIO | | | | | Bulfamante G.
Morte endouterina fetale: un problema, un libro, un progetto. Studio multicentrico italiano anatomo-clinico sulle malformazioni fetali: risultati preliminari |
| | | | |
| | | | Fulcheri E.
L'esame istopatologico della placenta per la comprensione delle alterazioni cardiotocografiche a termine di gravidanza: sorveglianza fetale in travaglio di parto |
| | | | |
| | | | Felis S.
Presentazione dello studio multicentrico italiano "EN.NE" (encefalopatia neonatale) |
| | | | |
| |
13:05 - 14:00
--TAVOLA ROTONDA | | | | | Bulfamante G.
Tra etica ed evoluzioni scientifiche. Il feto come paradigma della "difesa del più debole" o come materiale per l'avanzamento delle conoscenze diagnostico-terapeutiche? |
| | | | |
| |
|
| | | | |
| | | | | LEONARDO | 08:30 - 10:00
--PATHOLOGISTS OVERSEAS - PART 1 - SURGICAL PATHOLOGY AND INTERNATIONAL COOPERATION: REALITY AND PERSPECTIVES | | | | | Oberholzer M.
Globalization in medicine - A utopia or more? |
| | | | |
| | | | D.Soldini
"Patologi Oltre Frontiera" walk toward the Europe |
| | | | |
| | | | Camparo P.
Virtual pathology: concrete perspectives in a Franco-African collaboration |
| | | | |
| | | | Guzzetti S.
Cyto-histologic diagnosis on virtual slide |
| | | | |
| | | | Simonazzi S.
Technicians: web-based specialists |
| | | | |
| | | | Viberti L.
The role of Pap testing in low resource settings |
| | | | |
| |
10:30 - 11:30
--PATHOLOGISTS OVERSEAS - PART 2 - SURGICAL PATHOLOGY AND INTERNATIONAL COOPERATION: PROJECTS AND FUTURE | | | | | Massarelli G., Nogales F.F.
International cooperation in surgical pathology in Latin America |
| | | | |
| | | | Lee V.W.
Improving Pathology Services in Developing Countries - Experiences from the North American Community |
| | | | |
| | | | Giovenali P.
Patologi Oltre Frontiera: Palestine project and the Italian models of cooperation |
| | | | |
| |
|
| | | | |
| | | | | MASACCIO | 08:30 - 10:00
--SESSIONE DEI GIOVANI PATOLOGI COSA FARÒ DA GRANDE | | | | | Camboni A.
Prospettive occupazionali in Italia e all'Estero |
| | | | |
| | | | Ruco L.
L'occupazione temporanea nelle Scuole di Specializzazione |
| | | | |
| | | | Della Rocca C.
L'alternativa dell'attività nel privato |
| | | | |
| | | | Molinaro L.
La cooperazione internazionale ed il volontariato |
| | | | |
| | | | Cocca M.P.
L'anatomo-patologa: un lavoro di genere? |
| | | | |
| |
10:30 - 13:30
--MOLECULAR PATHOLOGY - MOLECULAR PATHOLOGY SYMPOSIUM | | | | | Ninfo V.
Il grading nei tumori dei tessuti molli |
| | | | |
| | | | Mikuz G.
Il grading nei tumori urologici |
| | | | |
| | | | Bianchi S.
Il grading nel carcinoma della mammella |
| | | | |
| | | | Zannoni G.F.
Il grading nel carcinoma dell'endometrio |
| | | | |
| | | | Gentili C.
Grading e test di concordanza su immagini digitali in patologia mammaria, cervicale, uroteliale e prostatica. Un'esperienza dei patologi toscani |
| | | | |
| |
|
| | | | |
| | | | | MICHELANGELO | 08:30 - 11:30
--SOFT TISSUE TUMOURS - THE CLINICAL RELEVANCE OF SARCOMA CLASSIFICATION | | | | | Dei Tos A.P.
The clinical relevance of sarcomas classification | |
| | | | |
| | | | Helman L.
The use of preclinical data in drafting new strategies for treating round cell sarcomas | |
| | | | |
| | | | Fletcher J.
Signalling pathways in GIST: beyond KIT and PDGFRA | |
| | | | |
| | | | Casali P.
Going beyond ifosfamide and anthracyclins: a histotype related therapeutic approach in adults STT | |
| | | | |
| |
11:30 - 12:30
--PLENARY AWARD SESSION | | | | | Kurrer M.
Intact B cell follicles identify mixed cellularity (MC) Hodgkin lymphomas (HL) with clinical and prognostic feaures of lymphocyte rich classical HL (CHL) | |
| | | | |
| | | | Molinari F.
More sensitive methods to identify K-RAS mutations increase the detection of non-responder in metastatic colorectal cancer (MCRC) patients treated with anti-EGFR monoclonal antibodies (MoAbs) | |
| | | | |
| |
12:30 - 13:30
--KEYNOTE LECTURE | | |
13:30 - 14:00
CLOSING CEREMONY | | |
|
| | | | |
| | | | | RAFFAELLO | 08:30 - 11:30
--ENDOCRINE PATHOLOGY - DISSECTING MALIGNANCY IN ENDOCRINE NEOPLASIA: MORPHOLOGY VS MOLECULAR BIOLOGY | | | | | Kovacs K.
Assessing malignancy in pituitary neoplasms: morphology vs molecular biology |
| | | | |
| | | | Gill A.
Parathyroid carcinoma |
| | | | |
| | | | Sobrinho Simões M.
Uncommon thyroid lesions |
| | | | |
| | | | Tischler A.S.
Dissecting malignancy in pheochromocytoma and extra-adrenal paraganglioma |
| | | | |
| | | | McNicol A.M.
Adrenal cortex |
| | | | |
| |
|
| | | | |
| | | | | VASARI | 08:30 - 11:30
--ORAL PRESENTATIONS - DIGESTIVE DISEASES PATHOLOGY | | | | | Bravou V.
Expression of P-SMAD2 and SNON in GISTS |
| | | | |
| | | | Karamitopoulou E.
Systematic analysis of proteins from different signalling pathways in the tumour centre and the invasive front of colorectal cancer |
| | | | |
| | | | Karamitopoulou E.
The multi-marker phenotype EphB2/bcl2/ Laminin5g2 differentiates between low grade and high grade tumour budding in colorectal cancer |
| | | | |
| | | | Musulen E.
Screening for Lynch syndrome in a series of 869 colorectal carcinomas |
| | | | |
| | | | Jimeno M.
Diagnosis of colonic adenomas with confocal endoscopy by inexperienced pathologist and endoscopyst |
| | | | |
| | | | Michailidi C.
Expression and methylation profile of DNA repair genes in Greek colon adenocarcinoma patients |
| | | | |
| | | | Mescoli C.
Long-term prognostic impact of isolated tumour cells in PN0 colorectal cancer |
| | | | |
| | | | Molaei M.
Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions? |
| | | | |
| | | | De Hertogh G.
Expression of barrier genes in the colonic mucosa of IBD patients |
| | | | |
| | | | El-Zimaity Mt.H.
Gastric atrophy diagnostic accuracy: comparison of OLGA and Baylor with serum biomarkers |
| | | | |
| | | | Fassan M.
Programmed cell death 4 (PDCD4) protein in esophageal cancer |
| | | | |
| | | | Mescoli C.
Prognostic impact of isolated tumour cells in PN0 esophageal cancer |
| | | | |
| | | | Tosi P.
Intercountry (Italy-Japan) agreement and residual discrepancies in the diagnosis of superficial gastric lesions after Paris and Vienna classifications |
| | | | |
| | | | Baruti A.
Expression of genotypes CagA and VacA and their correlation with hystophathological changes in Hp chronic gastritis |
| | | | |
| | | | Sakamoto K.
Pleomorphic phenotypes of gastrointestinal stromal tumours (GISTS) at metastatic sites, 145 lesions in 30 autopsy cases without imatinib treatment |
| | | | |
| |
|
| | | | |
|